Mosaico HIV-prevention vaccine study opening soon


Promising HIV vaccine to be tested with gay men and trans people

This article is a helpful overview of Mosaico, a global HIV-prevention vaccine study enrolling 3,800 sexually active HIV-negative gay men and transgender people age 18-60.